IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...
The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...
A specific Medicare Advantage plan has sparked confusion online after a new deductible took effect this year. The Cigna True ...
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...
Given forthcoming changes to Medicare Part D plans under the Inflation Reduction Act, CMS should collect and publish ...
HealthDay on MSN4d
Medicare to Negotiate Prices for 15 More Drugs, Including OzempicMedicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.
Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly ...
Trump has reversed some of President Biden’s initiatives, including $2 monthly out-of-pocket cap on some generics and ...
Medicare has undergone several major changes since it launched in 1965. And now, with the passage of the Inflation Reduction Act of 2022, it’s poised to change again, with several key provisions ...
Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback